- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Beta Bionics, Inc.: Beta Bionics to Announce Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026 | 2 | GlobeNewswire (USA) | ||
| Mi | Faruqi & Faruqi LLP: SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics | 233 | Newsfile | Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses in Beta Bionics to Contact Him Directly to Discuss Their OptionsIf you... ► Artikel lesen | |
| 09.01. | Beta Bionics Shares Tumble 33% | 2 | RTTNews | ||
| 09.01. | Beta Bionics Key KPI Miss Targets, Analyst Flags Valuation Risks | 1 | Benzinga.com | ||
| 09.01. | Analysts downgrade Beta Bionics on new patient starts miss | 3 | MassDevice | ||
| 09.01. | BofA Securities downgrades Beta Bionics stock to Neutral on valuation concerns | 2 | Investing.com | ||
| BETA BIONICS Aktie jetzt für 0€ handeln | |||||
| 08.01. | Beta Bionics reports Strong Preliminary Q4 2025 Topline Growth | 1 | Seeking Alpha | ||
| 08.01. | Beta Bionics, Inc.: Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics | 338 | GlobeNewswire (Europe) | IRVINE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its preliminary... ► Artikel lesen | |
| 08.01. | Beta Bionics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 08.12.25 | Beta Bionics, Inc.: Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026 | 1 | GlobeNewswire (USA) | ||
| 29.10.25 | Beta Bionics raises 2025 revenue guidance to $96.5M and projects Q4 gross margin improvement amid pharmacy channel expansion | 2 | Seeking Alpha | ||
| 28.10.25 | Beta Bionics, Inc. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 28.10.25 | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | 1.068 | GlobeNewswire (Europe) | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| 28.10.25 | Beta Bionics, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 20.10.25 | Stifel resumes Beta Bionics stock coverage with Buy rating on iLet adoption | 1 | Investing.com | ||
| 20.10.25 | Stifel: Kaufempfehlung für Beta Bionics dank starker iLet-Marktakzeptanz | 4 | Investing.com Deutsch | ||
| 17.10.25 | Beta Bionics stock reaffirmed Buy at Truist Securities on strong growth outlook | 1 | Investing.com | ||
| 09.10.25 | Beta Bionics, Inc.: Beta Bionics to Announce Third Quarter 2025 Financial Results on October 28, 2025 | 2 | GlobeNewswire (USA) | ||
| 01.10.25 | Forecasting The Future: 4 Analyst Projections For Beta Bionics | 1 | Benzinga.com | ||
| 01.10.25 | Wachstum bei Diabetestechnologie: Goldman Sachs stuft Beta Bionics auf "Buy" hoch | 6 | Investing.com Deutsch |
1 2 Weiter >>
32 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 16,180 | +0,12 % | Eckert & Ziegler: Tagesgewinner im SDAX und TecDAX am 09. Januar | ||
| HIMS & HERS HEALTH | 26,860 | -0,26 % | 4 Analysts Have This To Say About Hims & Hers Health | ||
| RADNET | 63,00 | 0,00 % | RadNet, Inc. - 8-K, Current Report | ||
| PROCEPT BIOROBOTICS | 30,520 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,610 | +3,02 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| INFUSYSTEM | 7,350 | -0,68 % | InfuSystem Holdings, Inc - 8-K, Current Report | ||
| IRADIMED | 88,00 | 0,00 % | CEO Of iRadimed Makes $487K Sale | ||
| KESTRA MEDICAL TECHNOLOGIES | 22,980 | +3,05 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Announces Strategic Collaboration with Biobeat Technologies to Expand Diagnostic Insight for Wearable Defibrillator Patients During Cardiac Recovery | KIRKLAND, Wash., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced a strategic... ► Artikel lesen | |
| FRESENIUS | 49,650 | -4,48 % | dpa-AFX-Überblick: UNTERNEHMEN vom 09.01.2026 - 15.15 Uhr | ROUNDUP: Teamviewer erreicht Umsatzziel für 2025 - Aktie mit Erholungsversuch GÖPPINGEN - Der Softwareanbieter Teamviewer hat 2025 sein im Herbst gesenktes Umsatzziel knapp erreicht. Basierend auf... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 36,780 | -0,51 % | EQS-Adhoc: Fresenius Medical Care AG: Fresenius Medical Care AG setzt Aktienrückkaufprogramm beschleunigt fort | EQS-Ad-hoc: Fresenius Medical Care AG / Schlagwort(e): Aktienrückkauf
Fresenius Medical Care AG: Fresenius Medical Care AG setzt Aktienrückkaufprogramm beschleunigt fort
09.01.2026... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 46,800 | -0,53 % | BERNSTEIN RESEARCH stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Siemens Healthineers auf "Outperform" mit einem Kursziel von 52,90 Euro belassen. 2025 sei ein schlechtes Jahr... ► Artikel lesen | |
| GENEDX | 109,28 | 0,00 % | Sema4.ai: Interview With Co-Founder & CEO Rob Bearden About The Enterprise AI Agent Platform | ||
| ALIGNMENT HEALTHCARE | 22,500 | 0,00 % | Alignment Healthcare Reports 31% Year-Over-Year Membership Growth to 275,300 as of Jan. 1, 2026 | Guides year-end 2026 health plan membership range of 290,000 to 296,000. Announces its expectation that consensus adjusted EBITDA of approximately $145 million in 2026 will be within its full-year... ► Artikel lesen | |
| HEARTFLOW | 36,120 | +3,26 % | Heartflow, Inc. - 8-K, Current Report | ||
| CARL ZEISS MEDITEC | 39,660 | -1,10 % | Bechtle, Carl Zeiss Meditec, CTS Eventim, MTU Aero Engines, Suss MicroTec, TeamViewer - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen |
Das Unternehmen BETA BIONICS INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 17,790 Euro und damit +4,71 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BETA BIONICS INC finden Sie auf Wallstreet Online.